Observational cohort study reveals declining attributable mortality in candidemia patients, indicating improved outcomes for common species while non-albicans infections remain lethal.
Although overall and attributable mortality in this subgroup analysis of matched case/control pairs remains high, the attributable mortality appears to have decreased in comparison to historical cohorts. This decrease may be driven by improved prognosis of Candida albicans and Candida parapsilosis candidemia; whereas candidemia due to other Candida spp. exhibits a much higher attributable mortality.
No takes yet. Share an insight, caveat, or question.
Salmanton‐García et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: